{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T19:38:20Z","timestamp":1782243500912,"version":"3.54.5"},"reference-count":72,"publisher":"Portland Press Ltd.","issue":"3","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6,28]]},"abstract":"<jats:p>The cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-regulated anion channel, which is expressed on the apical plasma membrane (PM) of epithelial cells. Mutations in the CFTR gene cause cystic fibrosis (CF), one of the most common genetic diseases among Caucasians. Most CF-associated mutations result in misfolded CFTR proteins that are degraded by the endoplasmic reticulum quality control (ERQC) mechanism. However, the mutant CFTR reaching the PM through therapeutic agents is still ubiquitinated and degraded by the peripheral protein quality control (PeriQC) mechanism, resulting in reduced therapeutic efficacy. Moreover, certain CFTR mutants that can reach the PM under physiological conditions are degraded by PeriQC. Thus, it may be beneficial to counteract the selective ubiquitination in PeriQC to enhance therapeutic outcomes for CF. Recently, the molecular mechanisms of CFTR PeriQC have been revealed, and several ubiquitination mechanisms, including both chaperone-dependent and -independent pathways, have been identified. In this review, we will discuss the latest findings related to CFTR PeriQC and propose potential novel therapeutic strategies for CF.<\/jats:p>","DOI":"10.1042\/bst20221468","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T13:59:00Z","timestamp":1683208740000},"page":"1297-1306","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The multiple ubiquitination mechanisms in CFTR peripheral quality control"],"prefix":"10.1042","volume":"51","author":[{"given":"Shogo","family":"Taniguchi","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, School of Biological and Environmental Sciences, Kwansei Gakuin University, Hyogo 669-1330, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Biological and Environmental Sciences, Kwansei Gakuin University, Hyogo 669-1330, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5175-2224","authenticated-orcid":false,"given":"Tsukasa","family":"Okiyoneda","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Biological and Environmental Sciences, Kwansei Gakuin University, Hyogo 669-1330, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2023,5,4]]},"reference":[{"key":"2023062811303621900_BST-2022-1468CC1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fnins.2017.00185","article-title":"Protein quality control by molecular chaperones in neurodegeneration","volume":"11","year":"2017","journal-title":"Front. Neurosci."},{"key":"2023062811303621900_BST-2022-1468CC2","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1146\/annurev.biochem.052308.114844","article-title":"Biological and chemical approaches to diseases of proteostasis deficiency","volume":"78","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"2023062811303621900_BST-2022-1468CC3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10930-019-09831-w","article-title":"Protein quality control in the endoplasmic reticulum","volume":"38","year":"2019","journal-title":"Protein J."},{"key":"2023062811303621900_BST-2022-1468CC4","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1034\/j.1600-0854.2002.31102.x","article-title":"Secretory pathway quality control operating in Golgi, plasmalemmal, and endosomal systems","volume":"3","year":"2002","journal-title":"Traffic"},{"key":"2023062811303621900_BST-2022-1468CC5","doi-asserted-by":"publisher","first-page":"102074","DOI":"10.1016\/j.ceb.2022.02.008","article-title":"Protein quality control at the Golgi","volume":"75","year":"2022","journal-title":"Curr. Opin. Cell Biol."},{"key":"2023062811303621900_BST-2022-1468CC6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ceb.2011.04.012","article-title":"Protein quality control at the plasma membrane","volume":"23","year":"2011","journal-title":"Curr. Opin. Cell Biol."},{"key":"2023062811303621900_BST-2022-1468CC7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1152\/physiol.00058.2013","article-title":"Protein homeostasis at the plasma membrane","volume":"29","year":"2014","journal-title":"Physiology (Bethesda)"},{"key":"2023062811303621900_BST-2022-1468CC8","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3389\/fphar.2018.01100","article-title":"Peripheral protein quality control as a novel drug target for CFTR stabilizer","volume":"9","year":"2018","journal-title":"Front. Pharmacol."},{"key":"2023062811303621900_BST-2022-1468CC9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1083\/jcb.153.5.957","article-title":"COOH-terminal truncations promote proteasome-dependent degradation of mature cystic fibrosis transmembrane conductance regulator from post-Golgi compartments","volume":"153","year":"2001","journal-title":"J. Cell Biol."},{"key":"2023062811303621900_BST-2022-1468CC10","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1191542","article-title":"Peripheral protein quality control removes unfolded CFTR from the plasma membrane","volume":"329","year":"2010","journal-title":"Science"},{"key":"2023062811303621900_BST-2022-1468CC11","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1083\/jcb.200312018","article-title":"Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes","volume":"164","year":"2004","journal-title":"J. Cell Biol."},{"key":"2023062811303621900_BST-2022-1468CC12","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","year":"1989","journal-title":"Science"},{"key":"2023062811303621900_BST-2022-1468CC13","doi-asserted-by":"publisher","first-page":"a015016","DOI":"10.1101\/cshperspect.a015016","article-title":"Mechanisms of bicarbonate secretion: lessons from the airways","volume":"2","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2023062811303621900_BST-2022-1468CC14","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1146\/annurev.biochem.75.103004.142532","article-title":"CFTR function and prospects for therapy","volume":"77","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"2023062811303621900_BST-2022-1468CC15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nm.2715","article-title":"Cystic fibrosis: a mucosal immunodeficiency syndrome","volume":"18","year":"2012","journal-title":"Nat. Med."},{"key":"2023062811303621900_BST-2022-1468CC16","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/S2213-2600(16)30188-6","article-title":"Classification of CFTR mutation classes","volume":"4","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"2023062811303621900_BST-2022-1468CC17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1083\/jcb.201208083","article-title":"Fixing cystic fibrosis by correcting CFTR domain assembly","volume":"199","year":"2012","journal-title":"J. Cell Biol."},{"key":"2023062811303621900_BST-2022-1468CC18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cell.2011.11.024","article-title":"Correction of both NBD1 energetics and domain interface is required to restore delta F508 CFTR folding and function","volume":"148","year":"2012","journal-title":"Cell"},{"key":"2023062811303621900_BST-2022-1468CC19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.cell.2011.11.023","article-title":"Requirements for efficient correction of \u0394F508 CFTR revealed by analyses of evolved sequences","volume":"148","year":"2012","journal-title":"Cell"},{"key":"2023062811303621900_BST-2022-1468CC20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.molmed.2011.10.003","article-title":"CFTR: folding, misfolding and correcting the \u0394F508 conformational defect","volume":"18","year":"2012","journal-title":"Trends Mol. Med."},{"key":"2023062811303621900_BST-2022-1468CC21","doi-asserted-by":"publisher","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809","volume":"108","year":"2011","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2023062811303621900_BST-2022-1468CC22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1091\/mbc.E14-04-0935","article-title":"From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations","volume":"27","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"2023062811303621900_BST-2022-1468CC23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1042\/BJ20111566","article-title":"Dab2 is a key regulator of endocytosis and post-endocytic trafficking of the cystic fibrosis transmembrane conductance regulator","volume":"441","year":"2012","journal-title":"Biochem. J."},{"key":"2023062811303621900_BST-2022-1468CC24","doi-asserted-by":"publisher","first-page":"e0123131","DOI":"10.1371\/journal.pone.0123131","article-title":"\u0394f508 CFTR surface stability is regulated by DAB2 and CHIP-mediated ubiquitination in post-endocytic compartments","volume":"10","year":"2015","journal-title":"PLoS ONE"},{"key":"2023062811303621900_BST-2022-1468CC25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1600-0854.2006.00384.x","article-title":"Molecular basis of oligoubiquitin-dependent internalization of membrane proteins in mammalian cells","volume":"7","year":"2006","journal-title":"Traffic"},{"key":"2023062811303621900_BST-2022-1468CC26","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.devcel.2018.02.001","article-title":"Chaperone-independent peripheral quality control of CFTR by RFFL E3 ligase","volume":"44","year":"2018","journal-title":"Dev. Cell"},{"key":"2023062811303621900_BST-2022-1468CC27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2147\/CPAA.S100759","article-title":"Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives","volume":"8","year":"2016","journal-title":"Clin. Pharmacol."},{"key":"2023062811303621900_BST-2022-1468CC28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3389\/fphar.2016.00275","article-title":"CFTR modulators: shedding light on precision medicine for cystic fibrosis","volume":"7","year":"2016","journal-title":"Front. Pharmacol."},{"key":"2023062811303621900_BST-2022-1468CC29","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1091\/mbc.E13-05-0240","article-title":"VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1","volume":"24","year":"2013","journal-title":"Mol. Biol. Cell"},{"key":"2023062811303621900_BST-2022-1468CC30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/cts.12610","article-title":"Pharmacokinetic and drug-drug interaction profiles of the combination of tezacaftor\/ivacaftor","volume":"12","year":"2019","journal-title":"Clin. Transl. Sci."},{"key":"2023062811303621900_BST-2022-1468CC31","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"2023062811303621900_BST-2022-1468CC32","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"2023062811303621900_BST-2022-1468CC33","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jcf.2014.09.005","article-title":"Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation","volume":"13","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"2023062811303621900_BST-2022-1468CC34","doi-asserted-by":"publisher","first-page":"840649","DOI":"10.3389\/fmolb.2022.840649","article-title":"The ubiquitin ligase RNF34 participates in the peripheral quality control of CFTR (RNF34 role in CFTR PeriQC)","volume":"9","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"2023062811303621900_BST-2022-1468CC35","doi-asserted-by":"publisher","first-page":"5262","DOI":"10.3390\/ijms22105262","article-title":"Partial rescue of \u0394F508del-CFTR stability and trafficking defects by double corrector treatment","volume":"22","year":"2021","journal-title":"Int. J. Mol. Sci"},{"key":"2023062811303621900_BST-2022-1468CC36","doi-asserted-by":"publisher","first-page":"246ra297","DOI":"10.1126\/scitranslmed.3008889","article-title":"Some gating potentiators, including VX-770, diminish F508-CFTR functional expression","volume":"6","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"2023062811303621900_BST-2022-1468CC37","doi-asserted-by":"publisher","first-page":"246ra296","DOI":"10.1126\/scitranslmed.3008680","article-title":"Potentiator ivacaftor abrogates pharmacological correction of \u0394F508 CFTR in cystic fibrosis","volume":"6","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"2023062811303621900_BST-2022-1468CC38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/ph13040075","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) ubiquitylation as a novel pharmaceutical target for cystic fibrosis","volume":"13","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"2023062811303621900_BST-2022-1468CC39","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41467-017-00444-4","article-title":"Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell","volume":"8","year":"2017","journal-title":"Nat. Commun."},{"key":"2023062811303621900_BST-2022-1468CC40","doi-asserted-by":"publisher","first-page":"jcs228007","DOI":"10.1242\/jcs.228007","article-title":"The integral function of the endocytic recycling compartment is regulated by RFFL-mediated ubiquitylation of Rab11 effectors","volume":"132","year":"2019","journal-title":"J. Cell Sci."},{"key":"2023062811303621900_BST-2022-1468CC41","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1016\/j.str.2004.10.007","article-title":"Crystal structure of a FYVE-type zinc finger domain from the caspase regulator CARP2","volume":"12","year":"2004","journal-title":"Structure"},{"key":"2023062811303621900_BST-2022-1468CC42","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1073\/pnas.0307459101","article-title":"Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth","volume":"101","year":"2004","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2023062811303621900_BST-2022-1468CC43","first-page":"507","article-title":"Effects of expression of hRFI on adenoma formation and tumor progression in colorectal adenoma-carcinoma sequence","volume":"23","year":"2004","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2023062811303621900_BST-2022-1468CC44","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1074\/jbc.M610793200","article-title":"CARPs are ubiquitin ligases that promote MDM2-independent p53 and phospho-p53ser20 degradation","volume":"282","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2023062811303621900_BST-2022-1468CC45","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.cub.2008.04.017","article-title":"CARP-2 is an endosome-associated ubiquitin ligase for RIP and regulates TNF-induced NF-kappaB activation","volume":"18","year":"2008","journal-title":"Curr. Biol."},{"key":"2023062811303621900_BST-2022-1468CC46","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1093\/emboj\/cdg529","article-title":"CHIP activates HSF1 and confers protection against apoptosis and cellular stress","volume":"22","year":"2003","journal-title":"EMBO J."},{"key":"2023062811303621900_BST-2022-1468CC47","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1128\/MCB.00296-08","article-title":"CHIP deficiency decreases longevity, with accelerated aging phenotypes accompanied by altered protein quality control","volume":"28","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"2023062811303621900_BST-2022-1468CC48","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1016\/j.cub.2008.11.040","article-title":"CARP2 deficiency does not alter induction of NF-kappaB by TNFalpha","volume":"19","year":"2009","journal-title":"Curr. Biol."},{"key":"2023062811303621900_BST-2022-1468CC49","doi-asserted-by":"publisher","first-page":"105396","DOI":"10.1016\/j.nbd.2021.105396","article-title":"RNF34 ablation promotes cerebrovascular remodeling and hypertension by increasing NADPH-derived ROS generation","volume":"156","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"2023062811303621900_BST-2022-1468CC50","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/embor.2009.69","article-title":"The ER-resident ubiquitin-specific protease 19 participates in the UPR and rescues ERAD substrates","volume":"10","year":"2009","journal-title":"EMBO Rep."},{"key":"2023062811303621900_BST-2022-1468CC51","doi-asserted-by":"publisher","first-page":"11314","DOI":"10.1074\/jbc.M109.044057","article-title":"Ubiquitin C-terminal hydrolase-L1 protects cystic fibrosis transmembrane conductance regulator from early stages of proteasomal degradation","volume":"285","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2023062811303621900_BST-2022-1468CC52","doi-asserted-by":"publisher","first-page":"18778","DOI":"10.1074\/jbc.M109.001685","article-title":"The deubiquitinating enzyme USP10 regulates the post-endocytic sorting of cystic fibrosis transmembrane conductance regulator in airway epithelial cells","volume":"284","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2023062811303621900_BST-2022-1468CC53","doi-asserted-by":"publisher","first-page":"e1001325","DOI":"10.1371\/journal.ppat.1001325","article-title":"A Pseudomonas aeruginosa toxin that hijacks the host ubiquitin proteolytic system","volume":"7","year":"2011","journal-title":"PLoS Pathog."},{"key":"2023062811303621900_BST-2022-1468CC54","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41589-022-00971-2","article-title":"Deubiquitinase-targeting chimeras for targeted protein stabilization","volume":"18","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"2023062811303621900_BST-2022-1468CC55","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1165\/rcmb.2018-0314OC","article-title":"-Nitrosylation of CHIP enhances F508Del-CFTR maturation","volume":"61","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2023062811303621900_BST-2022-1468CC56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/35050618","article-title":"The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins","volume":"3","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"2023062811303621900_BST-2022-1468CC57","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.bbamcr.2006.09.031","article-title":"CFTR surface expression and chloride currents are decreased by inhibitors of N-WASP and actin polymerization","volume":"1773","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"2023062811303621900_BST-2022-1468CC58","doi-asserted-by":"publisher","first-page":"19797","DOI":"10.1074\/jbc.273.31.19797","article-title":"An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton","volume":"273","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2023062811303621900_BST-2022-1468CC59","doi-asserted-by":"publisher","first-page":"40099","DOI":"10.1074\/jbc.M206964200","article-title":"PDZ domain interaction controls the endocytic recycling of the cystic fibrosis transmembrane conductance regulator","volume":"277","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2023062811303621900_BST-2022-1468CC60","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1091\/mbc.e09-03-0185","article-title":"Na+\/H+ exchanger regulatory factor 1 overexpression-dependent increase of cytoskeleton organization is fundamental in the rescue of F508del cystic fibrosis transmembrane conductance regulator in human airway CFBE41o- cells","volume":"21","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"2023062811303621900_BST-2022-1468CC61","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1091\/mbc.e06-08-0670","article-title":"Tracking of quantum dot-labeled CFTR shows near immobilization by C-terminal PDZ interactions","volume":"17","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"2023062811303621900_BST-2022-1468CC62","doi-asserted-by":"publisher","first-page":"ra48","DOI":"10.1126\/scisignal.aaa1580","article-title":"A molecular switch in the scaffold NHERF1 enables misfolded CFTR to evade the peripheral quality control checkpoint","volume":"8","year":"2015","journal-title":"Sci. Signal."},{"key":"2023062811303621900_BST-2022-1468CC63","doi-asserted-by":"publisher","first-page":"13396","DOI":"10.1074\/jbc.RA119.008738","article-title":"Inhibition of calpain 1 restores plasma membrane stability to pharmacologically rescued Phe508del-CFTR variant","volume":"294","year":"2019","journal-title":"J. Biol. Chem."},{"key":"2023062811303621900_BST-2022-1468CC64","doi-asserted-by":"publisher","first-page":"12602","DOI":"10.1096\/fj.201901050R","article-title":"CK19 stabilizes CFTR at the cell surface by limiting its endocytic pathway degradation","volume":"33","year":"2019","journal-title":"FASEB J."},{"key":"2023062811303621900_BST-2022-1468CC65","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1021\/cb300484r","article-title":"HGF stimulation of Rac1 signaling enhances pharmacological correction of the most prevalent cystic fibrosis mutant F508del-CFTR","volume":"8","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"2023062811303621900_BST-2022-1468CC66","doi-asserted-by":"publisher","first-page":"13026","DOI":"10.1038\/s41598-018-31514-2","article-title":"Prolonged co-treatment with HGF sustains epithelial integrity and improves pharmacological rescue of Phe508del-CFTR","volume":"8","year":"2018","journal-title":"Sci. Rep."},{"key":"2023062811303621900_BST-2022-1468CC67","doi-asserted-by":"publisher","first-page":"812101","DOI":"10.3389\/fmolb.2021.812101","article-title":"Treatment of polarized cystic fibrosis airway cells with HGF prevents VX-661-rescued F508del-CFTR destabilization caused by prolonged co-exposure to VX-770","volume":"8","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"2023062811303621900_BST-2022-1468CC68","doi-asserted-by":"publisher","first-page":"8099","DOI":"10.1074\/jbc.M611049200","article-title":"Targeting CAL as a negative regulator of DeltaF508-CFTR cell-surface expression: an RNA interference and structure-based mutagenetic approach","volume":"282","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2023062811303621900_BST-2022-1468CC69","doi-asserted-by":"publisher","first-page":"11211","DOI":"10.1073\/pnas.162027899","article-title":"Lack of acrosome formation in mice lacking a Golgi protein, GOPC","volume":"99","year":"2002","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2023062811303621900_BST-2022-1468CC70","doi-asserted-by":"publisher","first-page":"9907","DOI":"10.1002\/anie.201005585","article-title":"A stabilizing influence: CAL PDZ inhibition extends the half-life of \u0394F508-CFTR","volume":"49","year":"2010","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2023062811303621900_BST-2022-1468CC71","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3390\/pharmaceutics14040808","article-title":"Highway to cell: selection of the best cell-penetrating peptide to internalize the CFTR-stabilizing iCAL36 peptide","volume":"14","year":"2022","journal-title":"Pharmaceutics"},{"key":"2023062811303621900_BST-2022-1468CC72","doi-asserted-by":"publisher","first-page":"15773","DOI":"10.1021\/acs.jmedchem.0c01528","article-title":"Cyclic peptidyl inhibitors against CAL\/CFTR interaction for treatment of cystic fibrosis","volume":"63","year":"2020","journal-title":"J. Med. Chem."}],"container-title":["Biochemical Society Transactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/51\/3\/1297\/947739\/bst-2022-1468c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/51\/3\/1297\/947739\/bst-2022-1468c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T11:30:52Z","timestamp":1687951852000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article\/51\/3\/1297\/233016\/The-multiple-ubiquitination-mechanisms-in-CFTR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":72,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,5,4]]},"published-print":{"date-parts":[[2023,6,28]]}},"URL":"https:\/\/doi.org\/10.1042\/bst20221468","relation":{},"ISSN":["0300-5127","1470-8752"],"issn-type":[{"value":"0300-5127","type":"print"},{"value":"1470-8752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,4]]}}}